BioJet MRI/TRUS Fusion
MRI is not an effective tool for guiding a biopsy needle in real-time, but MRI is a superior imaging modality for visualizing areas of interest (possible cancer) Ultrasound cannot always visualize areas of interest (possible cancer), but it is a superior tool for guiding a biopsy needle in real-time Based upon these advantages and limitations of MRI and Ultrasound DK Technologies developed the BioJet 3-D MRI/US Fusion Prostate Biopsy System. BioJet is a flexible, advanced navigation platform that enables an accurate detection of suspicious lesions by combining MRI and real-time Ultrasound. It is a safer and a more effective alternative to a standard ultrasound guided prostate biopsy, which in fact, has several limitations. It can miss significant lesions but can detect less aggressive tumors by coincidence. This may lead to an underestimation of the patient’s clinical situation. No one wants a random diagnosis year after year. The BioJet MRI guided fusion prostate biopsy instead, enables enhanced detection and control of regions of interest and can reach MRI visible tumors with extremely high precision. This technology will dramatically change the way prostate cancer is managed and treated today.